Isaac Ro
Partner @ Catalio Capital Management
New York, United States
Isaac Ro is a Series A investor at Catalio Capital Management in New York focused on Biopharma and Health Care. Isaac Ro is based out of New York, New York, and is a Partner at Catalio Capital Management and also Board of Directors of Seer. Isaac previously worked at Pillar Biosciences as a Board Observer. Isaac Ro attended the Middlebury College.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Isaac Ro invests in
Stages Isaac Ro invests in
Countries Isaac Ro invests in
Investment Focus
Industry
- Biopharma 2 (67%)
- Health Care 2 (67%)
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series D 1 (33%)
- Venture - Series Unknown 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Visby Medical
|
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools thatare both highly accurate and delightful to use. | $55M / Venture - Series Unknown / Jun 17, 2025 | |
PrognomiQ
|
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data. | $34.3M / Series D / Nov 05, 2024 | |
PinkDx
|
PinkDx is a biotechnology company. | $40M / Series A / Apr 25, 2024 |
Co-Investors
aMoon Fund
1 deal together
Blue Water Life Science Advisors
1 deal together
Bruker
1 deal together
Cedars Sinai
1 deal together
Invus
1 deal together
About Catalio Capital Management
Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.
Catalio Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ben Snedeker
Partner and Co-Head Public Equities
|
|||
George Petrocheilos
Co-Founder & Managing Partner
|
|||
|
Isaac Ro
Partner
|
|||
Jacob Vogelstein
Co-Founder and Managing Partner
|
|||
Kenan Turnacioglu
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Isaac Ro invest in?
Isaac Ro invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series A and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Isaac Ro last invest?
The most recent investment recorded for Isaac Ro closed in Jun 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
